Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Escherichia Coli and Klebsiella Pneumoniae Isolated From Aleppo University Hospitals, Aleppo, Syria

Ibrahim AL-Subol 1 , * and Nihad Youssef 1
Authors Information
1 Department of Botany, Faculty of Sciences, University of Aleppo, Aleppo, Syria
Article information
  • Archives of Clinical Infectious Diseases: April 1, 2015, 10 (2); e22540
  • Published Online: April 22, 2015
  • Article Type: Research Article
  • Received: August 4, 2014
  • Revised: January 21, 2015
  • Accepted: February 8, 2015
  • DOI: 10.5812/archcid.22540

To Cite: AL-Subol I, Youssef N. Prevalence of CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Escherichia Coli and Klebsiella Pneumoniae Isolated From Aleppo University Hospitals, Aleppo, Syria, Arch Clin Infect Dis. 2015 ; 10(2):e22540. doi: 10.5812/archcid.22540.

Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Toroglu S, Keskin D. Antimicrobial Resistance and Sensitivity among Isolates of Klebsiella pneumoniae from Hospital Patients in Turkey. Int. J Agric Biol. 2011; 13(1): 941-6
  • 2. Kim MH, Lee HJ, Park KS, Suh JT. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea. Yonsei Med J. 2010; 51(5): 768-74[DOI][PubMed]
  • 3. Lim KT, Yeo CC, Yasin RM, Balan G, Thong KL. Characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals. J Med Microbiol. 2009; 58: 1463-9[DOI][PubMed]
  • 4. Wang XR, Chen JC, Kang Y, Jiang N, An SC, Gao ZC. Prevalence and characterization of plasmid-mediated blaESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniae in patients with pneumonia. Chin Med J (Engl). 2012; 125(5): 894-900[PubMed]
  • 5. Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Miyamoto Y, Higuchi T, et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum beta-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol. 2012; 137(4): 620-6[DOI][PubMed]
  • 6. Al-Agamy MH, Shibl AM, Hafez MM, Al-Ahdal MN, Memish ZA, Khubnani H. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. Ann Clin Microbiol Antimicrob. 2014; 13: 4[DOI][PubMed]
  • 7. Shanthi M, Sekar U. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. J Assoc Physicians India. 2010; 58 Suppl: 41-4[PubMed]
  • 8. Tonkic M, Goic-Barisic I, Punda-Polic V. Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol. 2005; 8(2): 119-24[PubMed]
  • 9. Ahmed OI, El-Hady SA, Ahmed TM, Ahmed IZ. Detection of bla SHV and bla CTX-M genes in ESBL producing Klebsiella pneumoniae isolated from Egyptian patients with suspected nosocomial infections. Egypt J Med Hum Gene. 2013; 14(3): 277-83[DOI]
  • 10. Batarseh A, Soneah S, Mardeni R, Elmadni K, Noor M, Ashour NA. antibiotic resistance patterns of multidrug resistant and extended-spectrum β -lactamase producing Esherichia coli urinary isolates at queen Rania al-abdullah hospital for children. Jordan Z U M J. 2013; 19(5): 286-93
  • 11. Ahmed OB, Omar AO, Asghar AH, Elhassan MM. Prevalence of TEM, SHV and CTX-M genes in Escherichia coli and Klebsiella spp. Urinary Isolates from Sudan with confirmed ESBL phenotype. Life Sci. 2013; 10(2): 191-5
  • 12. Alo MN, Anyim C, Igwe JC, Elom M. Presence of extended spectrum β-lactamase (ESBL) E. coli and K. pneumonia isolated from blood cultures of hospitalized patients. Adv Appl Sci Res. 2012; 3(2): 821-5
  • 13. Asghar AH. prevalence and potential types of extended spectrum β-lactamase among Escherishia coli and Klebsiella species in Makkah hospitals. Oxford Res forum J. 2007; 2(4): 47-55
  • 14. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother. 2009; 53(7): 2846-51[DOI][PubMed]
  • 15. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Shyr JM, Wan JH, et al. Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother. 2006; 50(5): 1861-4[DOI][PubMed]
  • 16. Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, et al. Nosocomial and community infections due to class A extended-spectrum beta-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis. 2011; 15(2): 138-43[PubMed]
  • 17. Goyal A, Prasad KN, Prasad A, Gupta S, Ghoshal U, Ayyagari A. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors. Indian J Med Res. 2009; 129(6): 695-700[PubMed]
  • 18. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G, et al. CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother. 2006; 50(8): 2700-6[DOI][PubMed]
  • 19. Rao SP, Rama PS, Gurushanthappa V, Manipura R, Srinivasan K. Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka. J Lab Physicians. 2014; 6(1): 7-13[DOI][PubMed]
  • 20. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother. 2007; 51(8): 2855-60[DOI][PubMed]
  • 21. Khan E, Schneiders T, Zafar A, Aziz E, Parekh A, Hasan R. Emergence of CTX-M Group 1-ESBL producing Klebsiella pneumonia from a tertiary care centre in Karachi, Pakistan. J Infect Dev Ctries. 2010; 4(8): 472-6[PubMed]
  • 22. Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zerouali K, et al. Characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol. 2011; 60: 1344-52[DOI][PubMed]
  • 23. Okesola AO, Oni AA. Prevalence of extended-spectrum β-lactamase producing Klebsiella in a tertiary care hospital in South West Nigeria. Int J Pharm Biomed Sci. 2012; 3(4): 148-51
  • 24. Brinas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother. 2005; 56(6): 1107-10[DOI][PubMed]
  • 25. Wei TY, Charles W. Advanced Techniques in Diagnostic Microbiology. 2006;
  • 26. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement . 2010;
  • 27. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4): 657-86[DOI][PubMed]
  • 28. Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis. 2011; 64(3): 249-52[PubMed]
  • 29. Coque TM, Oliver A, Perez-Diaz JC, Baquero F, Canton R. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother. 2002; 46(2): 500-10[PubMed]
  • 30. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res Notes. 2010; 3: 348[DOI][PubMed]
  • 31. Alfaresi MS, Elkoush AA. Real-time polymerase chain reaction for rapid detection of genes encoding SHV extended-spectrum beta-lactamases. Indian J Med Microbiol. 2010; 28(4): 332-6[DOI][PubMed]
  • 32. Nasehi L, Shahcheraghi F, Nikbin VS, Nematzadeh S. PER, CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran. Iran J Basic Med Sci. 2010; 13(3): 111-8
  • 33. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, et al. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol. 2007; 45(1): 199-205[DOI][PubMed]
  • 34. Ghafourian S, Bin Sekawi Z, Sadeghifard N, Mohebi R, Kumari Neela V, Maleki A, et al. The Prevalence of ESBLs Producing Klebsiella pneumoniae Isolates in Some Major Hospitals, Iran. Open Microbiol J. 2011; 5: 91-5[DOI][PubMed]
  • 35. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis. 2009; 13(6): 403-7[PubMed]
  • 36. Grobner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, et al. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol. 2009; 58: 912-22[DOI][PubMed]
  • 37. Roy S, Mukherjee S, Singh AK, Basu S. CTX-M-9 group extended-spectrum beta-lactamases in neonatal stool isolates: emergence in India. Indian J Med Microbiol. 2011; 29(3): 305-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments